Showing results (81-90 of 97) with videos related to
Sort By:
Pageof 10
Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association|February 5, 2013
Reproducible noninvasive method for evaluation of glenoid bone loss by multiplanar reconstruction curved computed tomographic imaging using a cadaveric modelMassimo De Filippo, Massimo de Filippo, Alessandro Castagna, et al.Hepatology (Baltimore, Md.)|September 12, 2015
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis BCarolina Boni, Pietro Lampertico, Lavinia Talamona, et al.Immunotherapy|February 19, 2020
Optimizing PD-L1 evaluation on cytological samples from advanced non-small-cell lung cancerCecilia Bozzetti, Anna Squadrilli, Rita Nizzoli, et al.Oncology Reports|October 4, 2019
High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancerFrancesca Negri, Cecilia Bozzetti, Giuseppe Pedrazzi, et al.Journal of Medical Imaging and Radiation Sciences|March 8, 2022
COVID-19 outbreak impact on health professionals: A survey on the Italian radiographer experienceChiara Martini, Camilla Risoli, Marco Nicolò, et al.Fetal Diagnosis and Therapy|August 20, 2018
The Effect of Chorionicity on Maternal Cardiac Adaptation to Uncomplicated Twin Pregnancy: A Prospective Longitudinal StudyTullio Ghi, Andrea Dall'Asta, Laura Franchi, et al.Frontiers in Oncology|March 17, 2023
Notch-Jagged1 signaling and response to bevacizumab therapy in advanced colorectal cancer: A glance to radiomics or back to physiopathology?Francesca Negri, Lorena Bottarelli, Giuseppe Pedrazzi, et al.Future Oncology (London, England)|November 10, 2015
Strong Notch activation hinders bevacizumab efficacy in advanced colorectal cancerFrancesca V Negri, Pellegrino Crafa, Giuseppe Pedrazzi, et al.JHEP Reports : Innovation in Hepatology|February 18, 2026
Transcriptional and functional HBV-specific CD8 T cell changes from disease to functional cure in HBeAg-negative chronic hepatitis BMarzia Rossi, Andrea Vecchi, Camilla Tiezzi, et al.Nature Communications|February 1, 2020
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infectionValeria Barili, Paola Fisicaro, Barbara Montanini, et al.Pageof 10